Search for: "Astrazeneca" Results 461 - 480 of 1,244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 May 2014, 6:54 pm
 The UK decision in Ranbaxy v AstraZeneca [2011]EWHC 1831 [on which see Katpost here] throws a little more light on this issue. [read post]
14 May 2014, 6:49 am
CanadaControversial overhaul of election rules pushed through by Conservatives, Vancouver SunMother of Amanda Todd fears cyberbullying bill could harm privacy rights, The National PostDriver of train in Lac-Megantic disaster seeks release from jail, ReutersUnited StatesOracle wins legal victory against Google in copyright ruling, ReutersRegulators propose scorecards to measure potential threat posed by firms offering risk models, ReutersInternationalBritish former head of GSK in China charges with… [read post]
7 May 2014, 6:29 am
CanadaAlberta’s PC government in 'full retreat' from contentious labour laws, The Globe and MailOntario Crown attorney’s office calls constitutional challenge of mandatory victim surcharge by Ottawa judges a 'brazen and very public insurrection', Ottawa CitizenCourt rules Canadian expats should regain voting rights, Toronto StarUnited StatesActivists sue San Francisco over controversial tech bus program, ReutersRegulators delay big banks from writing wills before a… [read post]
5 May 2014, 11:23 am by Paul Caron
Financial Times: Countries Slow Race to Bottom on Tax Competition: The proposed takeover of UK-listed drug group AstraZeneca by Pfizer of the US has reignited the debate over tax competition between countries. [read post]
5 May 2014, 5:58 am
.'s Labour party wants inquiry into Pfizer's AstraZeneca bid, ReutersReport notes pressure on Credit Suisse to plead guilty in tax dispute, Reuters [read post]
4 May 2014, 3:14 am by Mark Summerfield
  Specifically, in AstraZeneca AB v Alphapharm Pty Ltd [2014] FCA 419, the patentee has been awarded a higher level of attorney fees under section 19 of the Patents Act, which relates to Certificates of Validity. [read post]
3 May 2014, 8:56 am by Schachtman
After a long winter, the cherry trees are finally managing to blossom. [read post]
30 Apr 2014, 7:38 am
CanadaLori Douglas' husband dies, creates another hurdle for stalled Canadian Judicial Council inquiry, Toronto StarEngineer charged in Northern Ontario mall collapse wants parts of judicial report kept secret, Ottawa CitizenSPCA lawyer says petition to recognize animals as 'not things' in Quebec Civil Code could change legal status 'in various ways', Chronicle HeraldUnited StatesFormer AIG chief must face judge he accused of being biased, ReutersFine against BNP may… [read post]
30 Apr 2014, 3:21 am by Paul Caron
Following up on yesterday's post, Pfizer's Acquisition of AstraZeneca May Spur Rush of Tax-Avoidance Inversions: New York Times DealBook, How Tax Laws Distort the Pfizer Deal, by Victor Fleischer (San Diego): It’s tempting to look at the Pfizer deal simply as a loss for taxpayers in the United States. [read post]
29 Apr 2014, 11:52 am by Paul Caron
Mider: If Pfizer is successful in its $98.7 billion takeover of London-based AstraZeneca, there is one big potential loser: the U.S. [read post]
6 Mar 2014, 12:41 pm
AstraZeneca Pharmaceuticals, L.P., 351 S.W.3d 168 (Ark. 2009), the Arkansas Supreme Court construed that state’s safe harbor – for "permitted" activity − as precluding consumer protection claims involving statements made in advertising for FDA-approved products:Arkansas’s [statute] contains a safe harbor provision that specifically exempts conduct that is permitted under laws administered by a federal agency. . . . [read post]
24 Feb 2014, 11:19 am
It's unattractive when compared with bright sparkly pharma names like Actavis, Astellas, AstraZeneca, Novartis, Solvay or Teva. [read post]
19 Feb 2014, 9:09 am
 Tom has acted in AstraZeneca v KRKA (here) and the Nestle/Cadbury battle over the registrability of the four-fingered Kit Kat product as a trade mark.Well done, all of you! [read post]
14 Feb 2014, 8:01 am by Pete Strom
Reports of Heart Failure Lead to FDA Probe into AstraZeneca Diabetes Drugs On Tuesday, February 11th, the Food and Drug Administration (FDA) announced that they would review claims that AstraZeneca diabetes drug saxagliptin (Onglyza and Kombiglyze XR name brands) after reports that the drug can lead to heart disease or failure. [read post]
30 Jan 2014, 7:24 am
Coming only a few days after the decision of Sales J in Astrazeneca (& Another) v. [read post]
28 Jan 2014, 8:04 am by Robert Kraft
Bloomberg News reports the risks of cancer and liver toxicity from the diabetes medication from Bristol-Myers Squibb Co. and AstraZeneca Plc (AZN) “may outweigh any benefit the drug has on the heart,” according to FDA panel members. [read post]
27 Jan 2014, 12:51 pm
 This morning's PatLit carries a good descriptive analysis by Aaron Wood of last week's ruling over the Nexium patent in Astrazeneca v KRKA on what courts do when faced with successful defendant in infringement proceedings who, having been wrongfully tied down by a pre-trial injunction, seeks to cash in on the claimant's cross-undertaking in damages. [read post]